Rentschler Biopharma SE, a CDMO for biopharmaceuticals, is taking on new projects at its newest facility, in Milford, MA, including multispecific antibodies. The site will support both clinical and commercial manufacturing programs as the projects advance through development.   Karen Savage, Vice President and Milford site head, said, “The manufacture of biotherapeutics is rapidly evolving and requires novel technical solutions to match the increasing complexity. The Company’s new site in Milf...